TESTING PANELS

 

Pan Arrhythmia and Cardiomyopathy Panel (133 genes)

The Pan Arrhythmia and Cardiomyopathy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of arrhythmia and/or cardiomyopathy or identify at-risk individuals.


Pan Cardiomyopathy Panel (104 genes)

The Pan Cardiomyopathy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of cardiomyopathy or identify at-risk individuals.


Pan Arrhythmia Panel (66 genes)

The Pan Arrhythmia Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of arrhythmia or identify at-risk individuals.


Pan Aortopathy and Connective Tissue Disorders Panel (34 genes)

The Pan Aortopathy and Connective Tissue Disorders Panel is a comprehensive next-generation (NGS) panel that can be used to confirm a clinical diagnosis of an inherited aortopathy or connective tissue disorder or identify at-risk individuals.


Pan Pulmonary Hypertension Panel (11 genes)

The Pulmonary Hypertension Pan Panel is a comprehensive next-generation (NGS) panel that can be used to confirm a clinical diagnosis of pulmonary arterial hypertension or hereditary hemorrhagic telangiectasia.


Arrhythmogenic Cardiomyopathy Panel (23 genes)

The Arrhythmogenic Cardiomyopathy Panel is a comprehensive next-generation sequencing (NGS) panel that includes genes related to cardiomyopathy conditions with prominent arrhythmias. This test can be used to confirm a clinical diagnosis or identify at-risk individuals.


Brugada Syndrome Panel (20 genes)

The Brugada Syndrome Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Brugada syndrome or identify at-risk individuals.


Catecholaminergic Polymorphic Ventricular Tachycardia Panel (8 genes)

The Catecholaminergic Polymorphic Ventricular Tachycardia Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of catecholaminergic polymorphic ventricular tachycardia or identify at-risk individuals.


Dilated Cardiomyopathy Panel (67 genes)

The Dilated Cardiomyopathy Panel is a comprehensive next-generation sequencing panel that can be used to confirm a clinical diagnosis of dilated cardiomyopathy or identify at-risk individuals.


Ehlers-Danlos Syndrome Panel

The Ehlers-Danlos Syndrome Panel is a comprehensive next-generation (NGS) panel that can be used to confirm a clinical diagnosis of Ehlers-Danlos syndrome or identify or at-risk individuals.


Hereditary Hemorrhagic Telangiectasia Panel (5 genes)

The Hereditary Hemorrhagic Telangiectasia Panel is a comprehensive next-generation (NGS) panel that can be used to confirm a clinical diagnosis of hereditary hemorrhagic telangiectasia or identify at-risk individuals.


Hypertrophic Cardiomyopathy Panel (61 genes)

The Hypertrophic Cardiomyopathy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of hypertrophic cardiomyopathy or identify at-risk individuals.


Loeys-Dietz Syndrome Panel (6 genes)

The Loeys-Dietz Syndrome Panel is a comprehensive next-generation (NGS) panel that can be used to confirm a clinical diagnosis of Loeys-Dietz syndrome or identify or at-risk individuals.


Long QT Syndrome Panel (17 genes)

The Long QT Syndrome Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Long QT syndrome or identify at-risk individuals.


Left Ventricular Non-Compaction Cardiomyopathy Panel (19 genes)

The Left Ventricular Noncompaction Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of left ventricular noncompaction or identify at-risk individuals.


Marfan Syndrome Panel (1 gene)

The Marfan Syndrome Panel is a next-generation (NGS) panel that can be used to confirm a clinical diagnosis of Marfan syndrome or identify at-risk individuals.


Restrictive Cardiomyopathy Panel (10 genes)

The Restrictive Cardiomyopathy Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of restrictive cardiomyopathy or identify at-risk individuals.


Short QT Syndrome Panel (6 genes)

The Short QT Syndrome Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to confirm a clinical diagnosis of Short QT syndrome or identify at-risk individuals.